Korro Bio KRRO
NASDAQ KRRO
$14.41 -1.32 (-8.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Korro Bio (KRRO) Return on Invested Capital [ROIC] (2021 - 2022)

Updated

Korro Bio's Return on Invested Capital [ROIC] came in at -974.45% for Q4 2022, down 849.87 percentage points from -124.58% a year earlier and down 891.54 percentage points from the prior quarter.

Analysis

Korro Bio (KRRO) Return on Invested Capital [ROIC] (2021 - 2022) Analysis & Trends

For FY2021, Korro Bio's Return on Invested Capital [ROIC] was -93.22%, down 78.53 percentage points from FY2020.

  • Going back by year, Return on Invested Capital [ROIC] was -14.69% in FY2020.
  • Business Quant data shows KRRO's Return on Invested Capital [ROIC] at -82.91% (Q3 2022), -76.20% (Q2 2022) and -173.38% (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Korro Bio 281.05 Mn -128.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -974.45%
Sep 30, 2022 -82.91%
Jun 30, 2022 -76.20%
Mar 31, 2022 -173.38%
Dec 31, 2021 -124.58%
Sep 30, 2021 -42.51%
Mar 31, 2021 -21.05%
API Access

Korro Bio Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=KRRO&period=max&api_key=YOUR_API_KEY